NCT06687564View on ClinicalTrials.gov

Role of ACTG2 Variants in Smooth Muscle Determination and Function in Pediatric Intestinal Pseudo-obstruction.

NANot yet recruitingINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

November 30, 2030

Study Completion Date

November 30, 2030

Conditions
PIPO
Interventions
PROCEDURE

Biopsy

A skin biopsy and a blood sample will be taken to culture the iPS cells and intestinal organoids.

Trial Locations (3)

34295

Phymedexp Inserm U1046 - Cnrs Umr 9214, Montpellier

44035

Tens - Inserm Un Umr 1235, Nantes

75019

AP-HP Hôpital Robert Debré, Paris

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT06687564 - Role of ACTG2 Variants in Smooth Muscle Determination and Function in Pediatric Intestinal Pseudo-obstruction. | Biotech Hunter | Biotech Hunter